Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label, Dose-Titration Investigation of the Pharmacokinetics, Metabolism and Safety of Testosterone Transdermal Systems in Hypogonadal Men

NCT01104246 is registered in ClinicalTrials.gov with Watson Pharmaceuticals as lead sponsor.

NCT NCT01104246
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01104246 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label, Dose-Titration Investigation of the Pharmacokinetics, Metabolism and Safety of Testosterone Transdermal Systems in Hypogonadal Men
Lead sponsor
Watson Pharmaceuticals
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2010
Completion date
September 30, 2010
Enrollment
40 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

hypogonadism